Erythropoietin Inhibits Gluconeogenesis and Inflammation in the Liver and Improves Glucose Intolerance in High-Fat Diet-Fed Mice

Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury

(2012) Paola Cassis et al.   KIDNEY INTERNATIONAL

Effects of Continuous Erythropoietin Receptor Activator in Sepsis-Induced Acute Kidney Injury and Multi-Organ Dysfunction

(2012) Camila E. Rodrigues et al.   PLoS One

Erythropoietin Contrastingly Affects Bacterial Infection and Experimental Colitis by Inhibiting Nuclear Factor-κB-Inducible Immune Pathways

(2011) Manfred Nairz et al.   IMMUNITY

Erythropoietin Increases Survival and Attenuates Fulminant Hepatic Failure Injury Induced by d-Galactosamine/Lipopolysaccharide in Mice

(2011) Ziv Ben-Ari et al.   TRANSPLANTATION

Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production

(2011) Ruifeng Teng et al.   Nature Communications

The neuroprotective effect of erythropoietin-transduced human mesenchymal stromal cells in an animal model of ischemic stroke

(2010) Goang-Won Cho et al.   BRAIN RESEARCH

The role of excessive versus acute administration of erythropoietin in attenuating hepatic ischemia–reperfusion injury

(2010) Orit Pappo et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Erythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine models

(2010) Odelia Katz et al.   JOURNAL OF ENDOCRINOLOGY

Erythropoietin as Additive of HTK Preservation Solution in Cold Ischemia/Reperfusion Injury of Steatotic Livers

(2010) Christian Eipel et al.   JOURNAL OF SURGICAL RESEARCH

Increased Mitochondrial Oxidative Phosphorylation in the Liver Is Associated With Obesity and Insulin Resistance

(2010) David A. Buchner et al.   Obesity

Time-Resolved and Tissue-Specific Systems Analysis of the Pathogenesis of Insulin Resistance

(2010) Robert Kleemann et al.   PLoS One

rHuEPo Reduces Ischemia-Reperfusion Injury and Improves Survival After Transplantation of Fatty Livers in Rats

(2010) Maximilian Schmeding et al.   TRANSPLANTATION

Molecular Basis of Cardioprotection by Erythropoietin

(2010) D. Burger et al.   Current Molecular Pharmacology

Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation

(2009) Jean-François Tanti et al.   CURRENT OPINION IN PHARMACOLOGY

Effect of recombinant human erythropoietin on insulin resistance in hemodialysis patients

(2009) Essam KHEDR et al.   Hemodialysis International

Erythropoietin Over-Expression Protects against Diet-Induced Obesity in Mice through Increased Fat Oxidation in Muscles

(2009) Pernille Hojman et al.   PLoS One

Muscle-Specific IRS-1 Ser->Ala Transgenic Mice Are Protected From Fat-Induced Insulin Resistance in Skeletal Muscle

(2008) K. Morino et al.   DIABETES

The Metabolic Syndrome

(2008) Marc-Andre Cornier et al.   ENDOCRINE REVIEWS

Neural Progenitor Cells Treated with EPO Induce Angiogenesis through the Production of Vegf

(2008) Lei Wang et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Erythropoietin protects the human myocardium against hypoxia/reoxygenation injury via phosphatidylinositol-3 kinase and ERK1/2 activation

(2007) N R Mudalagiri et al.   BRITISH JOURNAL OF PHARMACOLOGY